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oBJectiVes
conclusion
The aim of this study was to assess the performance characteristics of the new Biotrin Parvovirus B19 IgM and IgG assays, adapted by Biotrin International to be fully automated on LIAISON® instrument (DiaSorin). We 
have compared this assay with the Biotrin International 4th generation enzyme immunoassay(1) performed on the Eti-max analyser (DiaSorin). 
(1) Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection, M. Enders et al., Journal of Virological Methods 146 (2007) 409-413 .
The LIAISON® Parvovirus B19 IgM and IgG assays appear to be a valid alternative for the detection of parvovirus B19 antibodies. Moreover, LIAISON® parvovirus IgG assay shows better specificity than 
Biotrin 4th generation EIA assay for results close to the equivocal range. These assays combine robust analytical and clinical performance with the advantage of fully automated, random access instrument system 




A total of 357 sera from routine daily practice were evaluated. 
GROUP 1 
137 sera for IgM and 160 sera for IgG were tested to evaluate the correlation between the two methods. 
GROUP 2 
Specificity of IgM LIAISON® Biotrin assay was assessed in detail by testing 60 serum samples with 
presence of potentially interfering antibodies 
Parvovirus B19 IgM and IgG EIA 4th generation Biotrin International and Biotrin LIAISON® methods are based on a sandwich antibody technique (IgM is also a µ-capture). The reagent used for both method 
is a VP2 recombinant antigen recombinant from parvovirus B19 (derived from baculovirus).
• We have not highlighted significant cross- reactions between parvovirus IgM and the other antibodies tested. 
• Intra-assay and inter-assay imprecision were less than 10% CV for both positive IgM and IgG samples.
• We have confirmed through paired sample testing that there is no cross-contamination effect for either the IgG 
  or IgM assays
Correlation between Biotrin EIA and LIAISON Biotrin assays:
The ability to semi-quantitate through the distri-
bution of low, medium, and high index samples, 
as with the Biotrin EIA IgG assay has been main-
tained with the LIAISON® kits.
There was observed a clear distribution of the 
positive and negative populations in terms of in-
dex results.
Discordant IgM result: 
Discordant results were re-tested a second or third time, and if still not resolved, were determined by 
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